FY23 in line; some hopes for recovery (H2 24)?

12/02/24 -"The group released an expected set of results, while it also anticipates a rather similar Q1 24 vs Q3 23. Even if the market is still depressed, particularly in Europe, a stabilisation is welcome and ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

12/02/24

Download

You may also be interested by these reports :

26/07/24

SSAB

The Q2 24 results aligned with market expectations. The US pricing environment continues to pressure the group, while activity levels in Europe ...

26/07/24

Anglo American

Anglo’s H1 results came in ahead of expectations. While the results were soft, there was healthy support from Copper and Iron Ore. Also, in other ...

25/07/24

Boliden

Boliden’s shares have again come under pressure in recent months despite the reassuring Q2 results and developments. However, what’s noteworthy and ...

25/07/24

AMAG

Support from the aluminum price – Slight increase of the guidance

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue

Aperam